SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001370368-20-000069
Filing Date
2020-07-21
Accepted
2020-07-21 09:38:39
Documents
66
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 6-K a200721-6k.htm 6-K 18927
2 99.1 FINANCIAL REPORT Q2 2020 a200721-99_1.htm EX-99 216938
3 99.2 INTERIM FINANCIAL REPORT a200721-99_2.htm EX-99 1968680
10 IMAGE logo.jpg GRAPHIC 26773
  Complete submission text file 0001370368-20-000069.txt   12165252

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nvs-20200630_cal.xml EX-101.CAL 64182
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nvs-20200630_def.xml EX-101.DEF 464677
6 XBRL INSTANCE DOCUMENT nvs-20200630.xml EX-101.INS 2847045
7 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT nvs-20200630_lab.xml EX-101.LAB 1728499
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nvs-20200630_pre.xml EX-101.PRE 488780
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nvs-20200630.xsd EX-101.SCH 487578
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-15024 | Film No.: 201037840
SIC: 2834 Pharmaceutical Preparations